Pharmacovigilance Outsourcing Market Scope
A pharmacovigilance outsourcing enables the clients to interact with one service provider for all the Pharmacovigilance (PV) and regulatory requirements, which translates into a cost and time-effective strategy. Pharmacovigilance outsourcing (PVO) transfers the execution of drug safety functions and processes to a third-party provider. These include primary PV activities like case processing, as well as governance activities like compliance management. These services are majorly outsourced by small and mid-size pharmaceutical and biotechnology companies with an aim to save costs and focus on the companyís core activities.
The market study is being classified and major geographies with country level break-up.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pharmacovigilance Outsourcing market throughout the predicted period.
Accenture plc (Ireland), Clinquest Group B.V (Netherlands), Cognizant (United States), Laboratory Corporation of America Holdings (United States), IBM (United States), ArisGlobal LLC (United States), ITClinical (Portugal), Foresight Group International AG (Switzerland), Take Solutions Ltd. (India) and Parexel International (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bioclinica (United States).
AdvanceMarketAnalytics has segmented the market of Global Pharmacovigilance Outsourcing market by Type, Application and Region.
On the basis of geography, the market of Pharmacovigilance Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In April 2018, HCL Technologies announced the acquisition of C3i Solutions, a leading service provider for life sciences and consumer packaged goods industries. The acquisition aimed at using C3iís expertise in the clinical, pharmacovigilance domain to accelerate the Indian IT firm's growth in life sciences.
- Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease
- Cost-effective Pharmacovigilance Services in Developing Countries
- High Profile Drug Recalls due to Safety Concerns
- High Potential in Developing Countries
- Increasing Adverse Drug Reactions Associated with Pharmaceutical Products Used in the Prevention and Treatment of Various Diseases
- The Risk associated with Data Security
- The Dearth of Skilled Personnel
Key Target AudiencePharmacovigilance Outsourcing Providers, Potential Investors, Research and Development Firm and End-User Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase